Proteomic Profiling of Cerebrospinal Fluid Identifies Biomarkers for Amyotrophic Lateral Sclerosis

Journal of Neurochemistry - United Kingdom
doi 10.1111/j.1471-4159.2005.03478.x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Proteomic Analysis of Cerebrospinal Fluid in Amyotrophic Lateral Sclerosis

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2016English

The Longitudinal Cerebrospinal Fluid Metabolomic Profile of Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
MedicineNeurology
2015English

Identification of Biomarkers for Amyotrophic Lateral Sclerosis by Comprehensive Analysis of Exosomal mRNAs in Human Cerebrospinal Fluid

BMC Medical Genomics
Genetics
2019English

Progress and New Frontiers in Biomarkers for Amyotrophic Lateral Sclerosis

Biomarkers in Medicine
BiochemistryDrug DiscoveryClinical Biochemistry
2018English

YKL40 in Sporadic Amyotrophic Lateral Sclerosis: Cerebrospinal Fluid Levels as a Prognosis Marker of Disease Progression

Aging
AgingCell Biology
2018English

Monoaminergic and Kynurenergic Characterization of Frontotemporal Dementia and Amyotrophic Lateral Sclerosis in Cerebrospinal Fluid and Serum

Neurochemical Research
MedicineBiochemistryCellularMolecular Neuroscience
2020English

Amyotrophic Lateral Sclerosis

2012English

Amyotrophic Lateral Sclerosis

2020English

Amyotrophic Lateral Sclerosis

Current Opinion in Neurology
Neurology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy